Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 11:05 AM ET 5/24/2013
Last 10 Quotes:
What's This?
Competitive Analysis
Competitive Analysis (cont.)
| Peregrine Pharmaceuticals Inc. | Dr. Reddy's Laboratories Ltd. ADS | AstraZeneca PLC ADS | Astrazeneca PLC | Shire PLC ADS | Qiagen N.V. | |
| Industry | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology |
| Current Share Price | 1.70 | 37.45 | 52.01 | 51.40 | 98.28 | 18.89 |
| Market Value | $222 mil | $6,258 mil | $64,593 mil | $64,593 mil | $17,811 mil | $4,424 mil |
| Revenues | $15 mil | $97,086 mil | $17,653 mil | $17,653 mil | $2,954 mil | $977 mil |
| Net Earnings | $-42 mil | $13,009 mil | $3,993 mil | $3,993 mil | $470 mil | $101 mil |
| 5-yr Sales Growth | 30.00% | 18.90% | 0.48% | 0.48% | 15.84% | 12.01% |
| 5-yr Earnings Growth | -0.76% | 38.99% | 7.45% | 7.45% | 85.87% | NA |
| Net Profit Margin | -165.25% | 12.06% | 20.96% | 20.96% | 12.24% | 9.60% |
| Short Interest | 4.43 | 3.44 | 1.61 | NA | 1.04 | 4.37 |
| Proj. Long-Term EPS Growth (%) | -21.96% | NA | -7.30% | -5.85% | 12.92% | 8.38% |
| Forward P/E | NA | 18.66 | 9.70 | 9.70 | 14.39 | 16.44 |
| PEG | NA | 1.08 | NA | NA | 1.34 | 1.68 |
| Price/Sales | 10.93 | 3.00 | 2.50 | 2.50 | 3.98 | 3.45 |
| Price/Cash Flow | NA | NA | 18.26 | 18.26 | 17.29 | 28.27 |
| Price/Book | 5.03 | 5.98 | 2.48 | 2.48 | 4.53 | 1.57 |
| ROE | -285.67% | 27.01% | 25.43% | 25.43% | 15.41% | 4.57% |
| ROA | -98.88% | 13.03% | 10.90% | 10.90% | 7.97% | 3.09% |
| Dividends | NA | $0.25 | $1.90 | $1.93 | $0.44 | NA |
| Dividend Yield | NA | 0.66% | 7.31% | 7.50% | 0.89% | NA |
| Payout Ratio | NA | 17.91% | 56.71% | 56.71% | 13.14% | 0.00% |
| Total Return (12-mos) | 187.95% | 23.33% | 26.32% | 25.31% | 9.73% | 14.59% |
| Total Return (3-yr) | -50.15% | 33.25% | 30.87% | 22.97% | 58.82% | -10.20% |
| Beta | 0.15 | 0.09 | 0.61 | 0.61 | 0.63 | 0.14 |
| % Off 52-wk High | 69.09% | 3.33% | 1.35% | 2.00% | 3.68% | 14.91% |
| % Above 52-wk Low | 302.56% | 37.28% | 30.94% | 28.98% | 22.72% | 20.63% |
| Consensus Analyst Recommendation | Buy | Overweight | Hold | Hold | Overweight | Hold |
